Serum calretinin as an independent predictor for platinum resistance and prognosis in ovarian cancer-Reference-Cited by-同舟云学术

Serum calretinin as an independent predictor for platinum resistance and prognosis in ovarian cancer

Published:2019-11-06 Issue:9 Volume:146 Page:2608-2618
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Link Theresa¹²³,Passek Simon¹²³,Wimberger Pauline¹²³,Frank Kerstin⁴,Vassileva Yana Damyanova¹²³,Kramer Michael⁵,Kuhlmann Jan Dominik¹²³^ORCID

Affiliation:

1. Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus Technische Universität Dresden Dresden Germany

2. National Center for Tumor Diseases (NCT), Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany Helmholtz‐Zentrum Dresden‐Rossendorf (HZDR) Dresden Germany

3. German Cancer Consortium (DKTK), Dresden and German Cancer Research Center (DKFZ) Heidelberg Germany

4. DRK‐Blood Donor Service, ITM Plauen Plauen Germany

5. Medizinische Klinik und Poliklinik I Medical Faculty and University Hospital, Technische Universität Dresden Dresden Germany

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32676

Reference33 articles.

1. Incidence of ovarian cancer by race and ethnicity in the United States, 1992-1997

2. 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)